APM (APM) Stock Price & Analysis
APM (APM) rose 0.00% to USD 0.7 as of July 25, 2026 at 03:01 UTC, according to Nexqual real-time market data.
APM last closed at USD 0; the session ranged USD 0.6–0.74 on volume of 195,145 shares. Market capitalization is $570,062, with a 52-week range of USD 0.6–44.7 (NCM). Source: Nexqual, July 25, 2026 at 03:01 UTC.
Key Statistics (as of July 25, 2026 at 03:01 UTC)
| Price | USD 0.7 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.7 |
| Day Range | USD 0.6 – 0.74 |
| 52-Week Range | USD 0.6 – 44.7 |
| Volume | 195,145 shares |
| Market Cap | $570,062 |
| Exchange | NCM |
Technical Analysis (APM)
Nexqual's technical model rates APM "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:01 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 71.41 (overbought) |
| vs SMA50 | Below (USD 2.77) |
| MACD | 1.97 (positive) |
Analyst Ratings (APM)
Wall Street analysts rate APM "None", per Nexqual as of July 25, 2026 at 03:01 UTC.
| Consensus Rating | None |
|---|
Earnings (APM)
Source: Nexqual, July 25, 2026 at 03:01 UTC.
Financials & Fundamentals (APM)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -10.79% |
| Debt / Equity | 25.05 |
| Current Ratio | 0.78 |
| Total Cash | $3.45M |
| Total Debt | $3.44M |
| Free Cash Flow | $-1.10M |
Source: Nexqual, July 25, 2026 at 03:01 UTC.
Financial Health Score (APM)
Nexqual rates APM's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 03:01 UTC.
| Growth | Critical — Revenue -16% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Solid — $3M cash vs $3M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$1M, burning cash |
| Efficiency | Critical — ROE -11%, ROA -6.5% |
Ownership (APM)
| Shares Outstanding | 634,682 |
|---|---|
| Float | 535,932 |
| Short % of Float | +1.07% |
Source: Nexqual, July 25, 2026 at 03:01 UTC.
Leadership (APM)
APM is led by Chung Yuen Huen (age 45), Founder, CEO & Executive Director, per Nexqual as of July 25, 2026 at 03:01 UTC.
| Founder, CEO & Executive Director | Chung Yuen Huen (age 45) |
|---|
Major Backers & Investors (APM)
Notable institutional backers of APM include Fidelity, Citadel, according to Nexqual as of July 25, 2026 at 03:01 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 1.13% |
| Citadel | 0.15% |
Source: Nexqual, July 25, 2026 at 03:01 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MEIP | MEI Pharma, Inc. | USD 3.07 | ▲ 10.43% |
| LAZR | Tema Photonics & Optical ETF | USD 38.62 | ▼ 6.1% |
| GRTX | Galera Therapeutics, Inc. | USD 16.28 | ▼ 2.51% |
| OTRK | Ontrak, Inc. | USD 0.33 | ▲ 358.33% |
| WW | WW International, Inc. | USD 13.34 | ▼ 9.56% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:01 UTC. This page is informational and not investment advice.